Targovax ASA (GB:0RIS) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Circio Holding ASA is advancing its innovative circular RNA technology, aiming to revolutionize nucleic acid medicine with its proprietary circVec platform. This technology promises enhanced and durable protein expression, positioning itself as a potential future standard in therapeutic applications. Additionally, Circio is actively developing a cancer vaccine, TG01, targeting KRAS mutations, with ongoing clinical trials in the USA and Norway.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
